However, like all medications, GLP-1 therapies come with potential side effects, such as gastrointestinal discomfort and risk for pancreatitis, necessitating careful medical supervision
Voir aussi le digestion, et pour une lipoprotine, la lipoprotine lipase
Curr Opin Drug Discov Devel
In a study of 83 men with obesity, functional hypogonadism, and insulin resistance, those treated with the dual glucose-dependent insulinotropic peptide and glucagon-like peptide 1 (GLP-1) receptor agonist tirzepatide for 2 months had greater weight loss, increased endogenous testosterone production, and improved erectile dysfunction compared to those treated with transdermal testosterone replacement therapy (TRT) or who received no treatment
Some patients require more hydration advice